Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

Moderna Gets Approval for mRNA Jab for Respiratory Syncytial Virus

In a win for its mRNA gene therapy technology used for its COVID-19 jabs, Moderna announced that the FDA has now granted a breakthrough-therapy designation for its respiratory syncytial virus. According to MarketWatch, “breakthrough-therapy designation aims to expedite the development and review of a drug for serious conditions when preliminary clinical evidence shows the drug may show substantial improvement over available therapies.” Currently, the designation would apply only...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports